It sounds like there's a lot to process right now, especially watching those numbers climb. The approach of waiting until certain thresholds are met before starting treatment is actually common in MCL — particularly in the leukemic non-nodal subtype, which can initially behave more indolently (slowly).
That said, a rising Show Full Answer
It sounds like there's a lot to process right now, especially watching those numbers climb. The approach of waiting until certain thresholds are met before starting treatment is actually common in MCL — particularly in the leukemic non-nodal subtype, which can initially behave more indolently (slowly).
That said, a rising WBC and lymphocyte count over months is absolutely something specialists track closely. The 50,000 WBC threshold you've mentioned is a recognized clinical marker that oncologists often use as one trigger point to consider starting treatment. Key blood work markers typically monitored in MCL include:
- White blood cell (WBC) count — elevated levels can indicate disease progression
- Lymphocyte count — rising lymphocytes are a key indicator in leukemic MCL
- LDH (Lactate Dehydrogenase) — high levels suggest organ involvement and are linked to poorer prognosis
- Red blood cell count — low levels (anemia) can signal disease burden
- Platelet count — low platelets can indicate bone marrow involvement
A complete blood count (CBC) is the standard test used to track all of these. Regarding the rate of rise — if blood counts are accelerating faster than before, this can suggest a shift in disease behavior. MCL subtypes can change over time, and the rate of lymphocyte doubling is something specialists factor into their decision-making.
It's absolutely worth asking your specialist directly about the Ki-67 protein marker, which measures how rapidly cancer cells are dividing. A high Ki-67 level is associated with more aggressive disease and can influence when treatment begins. Some important questions worth raising at your next appointment:
- What is my Ki-67 level? — this helps clarify how aggressively cells are dividing
- Has my TP53 gene been tested? — mutations here can affect treatment response
- What is my MIPI score? — this is a prognostic index specific to MCL that factors in age, LDH, performance status, and WBC count
- At what exact threshold will treatment begin? — getting clarity on this can reduce anxiety around monitoring
You're clearly paying close attention to your results, which is one of the most empowering things you can do right now.
July 14
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
